Literature DB >> 22316529

A virtual pyrogram generator to resolve complex pyrosequencing results.

Guoli Chen1, Matthew Theodore Olson, Alan O'Neill, Alexis Norris, Katie Beierl, Shuko Harada, Marija Debeljak, Keila Rivera-Roman, Samantha Finley, Amanda Stafford, Christopher David Gocke, Ming-Tseh Lin, James Richard Eshleman.   

Abstract

We report a freely available software program, Pyromaker, which generates simulated traces for pyrosequencing results based on user inputs. Simulated pyrograms can aid in the analysis of complex pyrosequencing results in which various hypothesized mutations can be tested, and the resultant pyrograms can be matched with the actual pyrogram. We validated the software using the actual pyrograms for common KRAS gene mutations as well as several mutations in the BRAF, GNAS, and p53 genes. We demonstrate that all 18 possible single-base mutations within codons 12 and 13 of KRAS generate unique pyrosequencing traces and highlight the distinctions between them. We further show that all reported codon 12 and 13 complex mutations produce unique pyrograms. However, some complex mutations are indistinguishable from single-base mutations. For complicated pyrograms, Pyromaker was used in two modes, one in which hypothesis-based simulated pyrograms were pattern-matched with the actual pyrograms. In a second strategy with only the pyrogram, Pyromaker was used to identify the underlying mutation by iteratively reconstructing the mutant pyrogram. Either strategy was able to successfully identify the complex mutations, which were confirmed by cloning and sequencing. Using two examples of KRAS codon 12 mutations (specifically GGT→TTT, G12F and GGT→GAG, G12E), we report which combinations of five approaches permit unambiguous mutation identification. The most efficient approach was found to be pyrosequencing with Pyromaker.
Copyright © 2012 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22316529      PMCID: PMC3349844          DOI: 10.1016/j.jmoldx.2011.12.001

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  20 in total

1.  Nearest-neighbor thermodynamics and NMR of DNA sequences with internal A.A, C.C, G.G, and T.T mismatches.

Authors:  N Peyret; P A Seneviratne; H T Allawi; J SantaLucia
Journal:  Biochemistry       Date:  1999-03-23       Impact factor: 3.162

2.  Endometrial K-ras mutations in postmenopausal breast cancer patients treated with adjuvant tamoxifen or toremifene.

Authors:  Mika Wallén; Eija Tomás; Tapio Visakorpi; Kaija Holli; Johanna Mäenpää
Journal:  Cancer Chemother Pharmacol       Date:  2004-11-20       Impact factor: 3.333

3.  Sensitive sequencing method for KRAS mutation detection by Pyrosequencing.

Authors:  Shuji Ogino; Takako Kawasaki; Mohan Brahmandam; Liying Yan; Mami Cantor; Chungdak Namgyal; Mari Mino-Kenudson; Gregory Y Lauwers; Massimo Loda; Charles S Fuchs
Journal:  J Mol Diagn       Date:  2005-08       Impact factor: 5.568

4.  Prevalence of ras gene mutations in human colorectal cancers.

Authors:  J L Bos; E R Fearon; S R Hamilton; M Verlaan-de Vries; J H van Boom; A J van der Eb; B Vogelstein
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

5.  Mismatches in DNA double strands: thermodynamic parameters and their correlation to repair efficiencies.

Authors:  H Werntges; G Steger; D Riesner; H J Fritz
Journal:  Nucleic Acids Res       Date:  1986-05-12       Impact factor: 16.971

6.  Enzymatic method for continuous monitoring of DNA polymerase activity.

Authors:  P Nyrén
Journal:  Anal Biochem       Date:  1987-12       Impact factor: 3.365

7.  A new method of sequencing DNA.

Authors:  E D Hyman
Journal:  Anal Biochem       Date:  1988-11-01       Impact factor: 3.365

8.  The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes.

Authors:  R W Ellis; D Defeo; T Y Shih; M A Gonda; H A Young; N Tsuchida; D R Lowy; E M Scolnick
Journal:  Nature       Date:  1981-08-06       Impact factor: 49.962

9.  Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene.

Authors:  L F Parada; C J Tabin; C Shih; R A Weinberg
Journal:  Nature       Date:  1982-06-10       Impact factor: 49.962

10.  KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib.

Authors:  William Pao; Theresa Y Wang; Gregory J Riely; Vincent A Miller; Qiulu Pan; Marc Ladanyi; Maureen F Zakowski; Robert T Heelan; Mark G Kris; Harold E Varmus
Journal:  PLoS Med       Date:  2005-01-25       Impact factor: 11.069

View more
  12 in total

1.  Patients with McCune-Albright syndrome have a broad spectrum of abnormalities in the gastrointestinal tract and pancreas.

Authors:  Laura D Wood; Michaël Noë; Wenzel Hackeng; Lodewijk A A Brosens; Feriyl Bhaijee; Marija Debeljak; Jun Yu; Masaya Suenaga; Aatur D Singhi; Atif Zaheer; Alison Boyce; Cemre Robinson; James R Eshleman; Michael G Goggins; Ralph H Hruban; Michael T Collins; Anne Marie Lennon; Elizabeth A Montgomery
Journal:  Virchows Arch       Date:  2017-02-10       Impact factor: 4.064

2.  Tumor cellularity as a quality assurance measure for accurate clinical detection of BRAF mutations in melanoma.

Authors:  Jonathan C Dudley; Grzegorz T Gurda; Li-Hui Tseng; Derek A Anderson; Guoli Chen; Janis M Taube; Christopher D Gocke; James R Eshleman; Ming-Tseh Lin
Journal:  Mol Diagn Ther       Date:  2014-08       Impact factor: 4.074

3.  Potential forensic biogeographic application of diatom colony consistency analysis employing pyrosequencing profiles of the 18S rDNA V7 region.

Authors:  Yuancun Zhao; Xiaogang Chen; Yiwen Yang; Xiaohong Zhao; Shu Zhang; Zehua Gao; Ting Fang; Yufang Wang; Ji Zhang
Journal:  Int J Legal Med       Date:  2018-05-07       Impact factor: 2.686

4.  BRAF pyrosequencing analysis aided by a lookup table.

Authors:  Matthew T Olson; Colleen Harrington; Katie Beierl; Guoli Chen; Michele Thiess; Alan O'Neill; Janis M Taube; Martha A Zeiger; Ming-Tseh Lin; James R Eshleman
Journal:  Am J Clin Pathol       Date:  2014-05       Impact factor: 2.493

5.  Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers.

Authors:  Patricia Aragon Han; Hyun-seok Kim; Soonweng Cho; Roghayeh Fazeli; Alireza Najafian; Hunain Khawaja; Melissa McAlexander; Benzon Dy; Meredith Sorensen; Anna Aronova; Thomas J Sebo; Thomas J Giordano; Thomas J Fahey; Geoffrey B Thompson; Paul G Gauger; Helina Somervell; Justin A Bishop; James R Eshleman; Eric B Schneider; Kenneth W Witwer; Christopher B Umbricht; Martha A Zeiger
Journal:  Thyroid       Date:  2016-03-07       Impact factor: 6.568

6.  A pyrosequencing-based assay for the rapid detection of the 22q11.2 deletion in DNA from buccal and dried blood spot samples.

Authors:  Deborah Koontz; Kirsten Baecher; Lisa Kobrynski; Stanimila Nikolova; Margaret Gallagher
Journal:  J Mol Diagn       Date:  2014-06-26       Impact factor: 5.568

7.  Clinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.

Authors:  Marco Dal Molin; Hanno Matthaei; Jian Wu; Amanda Blackford; Marija Debeljak; Neda Rezaee; Christopher L Wolfgang; Giovanni Butturini; Roberto Salvia; Claudio Bassi; Michael G Goggins; Kenneth W Kinzler; Bert Vogelstein; James R Eshleman; Ralph H Hruban; Anirban Maitra
Journal:  Ann Surg Oncol       Date:  2013-07-12       Impact factor: 5.344

8.  Clinical validation of KRAS, BRAF, and EGFR mutation detection using next-generation sequencing.

Authors:  Ming-Tseh Lin; Stacy L Mosier; Michele Thiess; Katie F Beierl; Marija Debeljak; Li-Hui Tseng; Guoli Chen; Srinivasan Yegnasubramanian; Hao Ho; Leslie Cope; Sarah J Wheelan; Christopher D Gocke; James R Eshleman
Journal:  Am J Clin Pathol       Date:  2014-06       Impact factor: 2.493

9.  A comparison of Direct sequencing, Pyrosequencing, High resolution melting analysis, TheraScreen DxS, and the K-ras StripAssay for detecting KRAS mutations in non small cell lung carcinomas.

Authors:  Sylwia Jancik; Jiri Drabek; Jitka Berkovcova; Yong Zhong Xu; Marcela Stankova; Jiri Klein; Vitezslav Kolek; Josef Skarda; Tomas Tichy; Ivona Grygarkova; Danuta Radzioch; Marian Hajduch
Journal:  J Exp Clin Cancer Res       Date:  2012-09-20

10.  Pyrosequencing data analysis software: a useful tool for EGFR, KRAS, and BRAF mutation analysis.

Authors:  Shanxiang Shen; Dahui Qin
Journal:  Diagn Pathol       Date:  2012-05-28       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.